Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

@article{Trosch2017MulticenterOS,
  title={Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry},
  author={Richard M. Trosch and Alberto J Espay and Daniel Truong and Ramon Gil and Carlos Singer and Peter A Lewitt and Mark F. Lew and Michele Tagliati and Charles H Adler and Jack J Chen and Dominic Marchese and Cynthia L. Comella},
  journal={Journal of the Neurological Sciences},
  year={2017},
  volume={376},
  pages={84-90}
}
BACKGROUND The ANCHOR-CD prospective observational registry study evaluated the effectiveness of abobotulinumtoxinA in adult idiopathic cervical dystonia (CD) in clinical practice. METHODS Adults with CD were eligible. Treating physicians determined abobotulinumtoxinA dose and treatment interval. The primary endpoint was patient response rate (Toronto Western Spasmodic Torticollis Rating Scale [TWSTRS] score reduction≥25% and Patient Global Impression of Change [PGIC] score of +2 or +3 at… CONTINUE READING